These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36077026)

  • 21. Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment.
    Radpour R; Barekati Z; Kohler C; Schumacher MM; Grussenmeyer T; Jenoe P; Hartmann N; Moes S; Letzkus M; Bitzer J; Lefkovits I; Staedtler F; Zhong XY
    PLoS One; 2011; 6(11):e27355. PubMed ID: 22076154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Centchroman altered the expressions of tumor-related genes through active chromatin modifications in mammary cancer.
    Khan S; Shukla S; Sinha S; Meeran SM
    Mol Carcinog; 2016 Nov; 55(11):1747-1760. PubMed ID: 26465660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combinatorial CRISPR/Cas9 Screening Reveals Epistatic Networks of Interacting Tumor Suppressor Genes and Therapeutic Targets in Human Breast Cancer.
    Zhao X; Li J; Liu Z; Powers S
    Cancer Res; 2021 Dec; 81(24):6090-6105. PubMed ID: 34561273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network.
    Zhou K; Liu M; Cao Y
    Front Mol Biosci; 2017; 4():46. PubMed ID: 28736730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X-Linked Tumor Suppressor Genes Act as Presumed Contributors in the Sex Chromosome-Autosome Crosstalk in Cancers.
    Dhabhai B; Sharma A; Maciaczyk J; Dakal TC
    Cancer Invest; 2022 Feb; 40(2):103-110. PubMed ID: 34519229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
    Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
    Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
    Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
    Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated oncogenes and putative tumor suppressor genes involved in human breast cancers.
    Tripathy D; Benz CC
    Cancer Treat Res; 1992; 63():15-60. PubMed ID: 1363356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
    Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
    Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioinformatic Analysis of Circadian Expression of Oncogenes and Tumor Suppressor Genes.
    Salavaty A; Mohammadi N; Shahmoradi M; Naderi Soorki M
    Bioinform Biol Insights; 2017; 11():1177932217746991. PubMed ID: 29276378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ICan: an integrated co-alteration network to identify ovarian cancer-related genes.
    Zhou Y; Liu Y; Li K; Zhang R; Qiu F; Zhao N; Xu Y
    PLoS One; 2015; 10(3):e0116095. PubMed ID: 25803614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
    Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes.
    Zhao M; Kim P; Mitra R; Zhao J; Zhao Z
    Nucleic Acids Res; 2016 Jan; 44(D1):D1023-31. PubMed ID: 26590405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TSGene: a web resource for tumor suppressor genes.
    Zhao M; Sun J; Zhao Z
    Nucleic Acids Res; 2013 Jan; 41(Database issue):D970-6. PubMed ID: 23066107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of epigenetically regulated genes in breast cancer cell lines.
    Loss LA; Sadanandam A; Durinck S; Nautiyal S; Flaucher D; Carlton VE; Moorhead M; Lu Y; Gray JW; Faham M; Spellman P; Parvin B
    BMC Bioinformatics; 2010 Jun; 11():305. PubMed ID: 20525369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.
    Cleton-Jansen AM; van Eijk R; Lombaerts M; Schmidt MK; Van't Veer LJ; Philippo K; Zimmerman RM; Peterse JL; Smit VT; van Wezel T; Cornelisse CJ
    BMC Cancer; 2008 Apr; 8():105. PubMed ID: 18416817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data.
    Hua Y; Gao L; Li X
    Pathol Oncol Res; 2021; 27():1609789. PubMed ID: 34408553
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of Differentially Expressed Genes Induced by Aberrant Methylation in Oral Squamous Cell Carcinomas Using Integrated Bioinformatic Analysis.
    Zhang X; Feng H; Li D; Liu S; Amizuka N; Li M
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29875348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative epigenomics of human and mouse mammary tumors.
    Demircan B; Dyer LM; Gerace M; Lobenhofer EK; Robertson KD; Brown KD
    Genes Chromosomes Cancer; 2009 Jan; 48(1):83-97. PubMed ID: 18836996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.